Dural sealant enters European trial:
This article was originally published in Clinica
Confluent Surgical has begun a single-site, European clinical trial of its sprayable synthetic sealant for reducing the rate of cerebrospinal fluid leakage in patients undergoing cranial and spinal surgical procedures. The sealant is indicated for use as an adjunct to standard methods of closure of the dura mater. The product is sprayed onto the tissue at the end of a surgical procedure. It forms a flexible, watertight seal, remains adhered to the tissue during the critical healing period and is then safely absorbed by the body, says the Waltham, Massachusetts firm.